Abstract
Aurora kinases are essential for the regulation of chromosome segregation and cytokinesis during mitosis and play a role in tumorigenesis and tumor progression in humans. Aurora kinase A and Aurora kinase B are overexpressed in some gynecologic cancers, and their overexpression is associated with poor prognosis. Thus, targeting of Aurora kinases has become an attractive strategy for pharmaceutical companies, who have developed more than 30 Aurora kinase inhibitors for treatment of cancers. Some of these inhibitors have been shown to be effective in targeted therapies for human cancer, and others are currently being investigated. In this review, we summarize the most recent advances in preclinical studies and clinical trials of patented Aurora kinase inhibitors for gynecologic tumors.
Keywords: Gynecologic malignancies, Aurora kinases, Aurora kinase inhibitors
Recent Patents on Anti-Cancer Drug Discovery
Title: Update on Aurora Kinase Inhibitors in Gynecologic Malignancies
Volume: 3 Issue: 3
Author(s): Xia Tao, Hye S. Chon, Siqing Fu, John J. Kavanagh and Wei Hu
Affiliation:
Keywords: Gynecologic malignancies, Aurora kinases, Aurora kinase inhibitors
Abstract: Aurora kinases are essential for the regulation of chromosome segregation and cytokinesis during mitosis and play a role in tumorigenesis and tumor progression in humans. Aurora kinase A and Aurora kinase B are overexpressed in some gynecologic cancers, and their overexpression is associated with poor prognosis. Thus, targeting of Aurora kinases has become an attractive strategy for pharmaceutical companies, who have developed more than 30 Aurora kinase inhibitors for treatment of cancers. Some of these inhibitors have been shown to be effective in targeted therapies for human cancer, and others are currently being investigated. In this review, we summarize the most recent advances in preclinical studies and clinical trials of patented Aurora kinase inhibitors for gynecologic tumors.
Export Options
About this article
Cite this article as:
Tao Xia, Chon S. Hye, Fu Siqing, Kavanagh J. John and Hu Wei, Update on Aurora Kinase Inhibitors in Gynecologic Malignancies, Recent Patents on Anti-Cancer Drug Discovery 2008; 3 (3) . https://dx.doi.org/10.2174/157489208786242322
DOI https://dx.doi.org/10.2174/157489208786242322 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Current Cancer Drug Targets Safety Issues of Vitamin D Supplementation
Anti-Cancer Agents in Medicinal Chemistry G Protein-coupled Receptors in Cancer Stem Cells
Current Pharmaceutical Design Pharmacogenetics of the Antiplatelet Effect of Aspirin
Current Pharmaceutical Design Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Towards Sustainability: New Approaches to Nano-Drug Preparation
Current Pharmaceutical Design Inhibitory Effects of Caffeic Acid Ester Analogues on Free Radicals and Human Liver Microsome CYP1A2 Activities
Medicinal Chemistry Recent Developments in the Synthesis and Biological Activity of Muramylpeptides
Current Medicinal Chemistry Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles
Current Alzheimer Research Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Vinorelbine in Cancer Therapy
Current Drug Targets Estrogen Receptors: Mechanism of Action and Relevance to Schizophrenia
Current Psychiatry Reviews Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Animal Models for Studying Neointima Formation
Current Vascular Pharmacology Subject Index To Volume 3
Current Pharmaceutical Biotechnology Progress in Topical siRNA Delivery Approaches for Skin Disorders
Current Pharmaceutical Design Breast Cancer: Not Only a “Womans” Disease
Current Women`s Health Reviews Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Antisense and/or Immunostimulatory Oligonucleotide Therapeutics
Current Cancer Drug Targets Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design